Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AstroNova | ALOT | Oct 17, 2024 | 14.18 | -1.18 |
Astrotech | ASTC | Oct 17, 2024 | 8.10 | 0.00 |
Asure Software | ASUR | Oct 17, 2024 | 9.23 | +0.44 |
AT&T | T | Oct 17, 2024 | 21.73 | +0.09 |
AT&T A Pref | T-A | Oct 17, 2024 | 22.50 | +0.27 |
AT&T C Pref | T-C | Oct 17, 2024 | 21.34 | +0.23 |
ATA Creativity Global ADR | AACG | Oct 17, 2024 | 1.00 | -0.99 |
Atai Life Sciences BV | ATAI | Oct 17, 2024 | 1.20 | -0.83 |
Atara Biotherapeutics | ATRA | Oct 17, 2024 | 9.38 | +1.96 |
Atea Pharmaceuticals | AVIR | Oct 17, 2024 | 3.73 | -1.06 |
Aterian | ATER | Oct 17, 2024 | 2.96 | -1.33 |
Athena Technology Acquisition II | ATEK | Oct 17, 2024 | 11.66 | -0.09 |
Athene A Pref | ATH-A | Oct 17, 2024 | 25.42 | -0.35 |
Athene B Pref | ATH-B | Oct 17, 2024 | 23.04 | -0.57 |
Athene C Pref | ATH-C | Oct 17, 2024 | 25.07 | +0.08 |
Athene D Pref | ATH-D | Oct 17, 2024 | 20.12 | -0.84 |
Athene Holding | ATH-E | Oct 17, 2024 | 26.87 | 0.00 |
Athira Pharma | ATHA | Oct 17, 2024 | 0.45 | -1.52 |
Ati Physical Therapy A | ATIP | Oct 17, 2024 | 6.24 | +5.76 |
ATIF Holdings | ATIF | Oct 17, 2024 | 0.89 | -0.63 |
Atkore | ATKR | Oct 17, 2024 | 88.64 | -0.39 |
Atlanta Braves A | BATRA | Oct 17, 2024 | 43.97 | +1.36 |
Atlanta Braves C | BATRK | Oct 17, 2024 | 41.07 | +1.01 |
Atlantic American | AAME | Oct 17, 2024 | 1.63 | +7.24 |
Atlantic Coastal Acquisition II A | ACAB | Oct 17, 2024 | 11.10 | 0.00 |
Atlantic Union Bank | AUB | Oct 17, 2024 | 39.55 | +0.48 |
Atlantic Union Bankshares A Pref | AUB-A | Oct 17, 2024 | 24.46 | -0.16 |
Atlantica Sustainable Infrastructure | AY | Oct 17, 2024 | 21.98 | -0.05 |
Atlanticus | ATLC | Oct 17, 2024 | 37.41 | +3.11 |
Atlanticus B Pref | ATLCP | Oct 17, 2024 | 22.90 | -0.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.